From AI-Assisted In Silico Computational Design to Preclinical In Vivo Models: A Multi-Platform Approach to Small Molecule Anti-IBD Drug Discovery
Pharmaceuticals · 13.10.2025 · 18 (10) · 1536
DOI: 10.3390/ph18101536 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 13.10.2025. Verfasst von Joya Datta Ripa und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Science and Engineering, Cairns Campus, James Cook University, Cairns, QLD 4878, Australia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC Ideas Grant, Post Graduate Research Scholarship (JCUPRS) by James Cook University.
Abstract (Originalsprache)
Background
Inflammatory Bowel Disease (IBD), including Ulcerative Colitis and Crohn’s Disease, is a multifactorial inflammatory condition of the intestinal tract driven by a complex interplay of genetic factors, immune system dysfunction, and gut microbiota alterations. This review aims to synthesize current advancements in modern drug development strategies for IBD. It emphasizes the integration of computational modelling, cell-based experiments, and animal model studies to enhance translational outcomes.
Methods
To compile this review, an extensive literature search was performed utilizing PubMed, Scopus, and Google Scholar databases for English-language research and review articles published between 2000 and 2025 using keywords such as “IBD,” “molecular docking,” “bioinformatics,” “organoids,” “animal models,” and “network pharmacology,” among others. A total of 199 peer-reviewed studies were identified for inclusion based on relevance, transparency, and methodological robustness.
Results
The review outlines a range of cutting-edge approaches to IBD drug discovery. These include computer modelling, molecular docking, and network analysis to accelerate early-stage target prediction and drug screening. The review further highlights the critical importance of utilizing 2D and 3D cell culture systems in parallel with advanced animal models. It emphasizes the critical integration of computational predictions with biologically relevant in vitro and in vivo validations to improve the reliability and efficiency of drug development.
Conclusions
The integration of computer modelling, cell culture systems, and animal studies provides a revolutionary paradigm for accelerating drug discovery to IBD and other diseases enabling personalized and more effective treatment approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Science and Engineering, Cairns Campus, James Cook University, Cairns, QLD 4878, Australia.
- Centre for Tropical Bioinformatics and Molecular Biology, Cairns Campus, James Cook University, Cairns, QLD 4878, Australia.
- Immunogenomics Lab, Garvan Institute of Medical Research, Darlinghurst, NSW 2000, Australia.
- College of Medicine and Dentistry, Townsville Campus, James Cook University, Townsville, QLD 4811, Australia.
ORCID-Profile: Matt Field, Phurpa Wangchuk
Förderung
- NHMRC Ideas Grant
- Post Graduate Research Scholarship (JCUPRS) by James Cook University
Zitieren
APA
Ripa, J. D., Ali, S., Field, M., Smithson, J., & Wangchuk, P. (2025). From AI-Assisted In Silico Computational Design to Preclinical In Vivo Models: A Multi-Platform Approach to Small Molecule Anti-IBD Drug Discovery. Pharmaceuticals, 18(10), 1536. https://doi.org/10.3390/ph18101536
Vancouver
Ripa JD, Ali S, Field M, Smithson J, Wangchuk P. From AI-Assisted In Silico Computational Design to Preclinical In Vivo Models: A Multi-Platform Approach to Small Molecule Anti-IBD Drug Discovery. Pharmaceuticals. 2025;18(10):1536. doi:10.3390/ph18101536
BibTeX
@article{Ripa2025,
author = {Ripa, Joya Datta and Ali, Sarfaraz and Field, Matt and Smithson, John and Wangchuk, Phurpa},
title = {From AI-Assisted In Silico Computational Design to Preclinical In Vivo Models: A Multi-Platform Approach to Small Molecule Anti-IBD Drug Discovery},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {10},
pages = {1536},
doi = {10.3390/ph18101536}
}
EUVIMED